The document discusses infectious rhinosinusitis and provides details on:
1. Rhinosinusitis is inflammation of the nose and paranasal sinuses characterized by nasal obstruction, discharge, facial pain and loss of smell. Acute rhinosinusitis is usually caused by viral infection but can become bacterial.
2. Chronic rhinosinusitis lasts over 12 weeks and is characterized by persistent inflammation not resolved by treatment. The role of bacteria is unclear but biofilms and osteitis may perpetuate inflammation.
3. Imaging like CT is used to confirm acute rhinosinusitis especially in severe cases, while most cases are diagnosed clinically. Treatment involves analgesics, decongestants and antibiotics if bacterial infection
Call Girls Rishikesh Just Call 9667172968 Top Class Call Girl Service Available
Infectious rhinosinusitis
1. INFECTIOUS
RHINOSINUSITIS
References-
•Cummings Otolaryngology Head & Neck Surgery 6th edition
•Scott-brown’s Otolaryngology, Head & Neck Surgery 7th edition
•Infectious Diseases Society of America (IDSA) Guideline for ABRS: CID. March 20, 2012
•European Position Paper on Rhinosinusitis and Nasal Polyps(EPOS) March 2012
Dr Vikas
2. Rhinosinusitis is a group of disorders characterized
by inflammation of the lining of the nose and
paranasal sinuses.
The ciliated respiratory mucosal lining of the nose
and paranasal sinuses are contiguous and it would
be rare for one to be affected without the other.
4. Pathophysiology
Acute rhinosinusitis develops in conjunction with an acute viral upper
respiratory tract infection.
Occur more commonly in predisposed individuals
The infection results in mucosal swelling with occlusion or
obstruction of the sinus ostia.
A reduction in oxygen tension occurs which can reduce mucociliary
transport and transudation of fluid into the sinuses.
The inflammation also results in changes in the mucous that
become more viscous and alterations in cilia beat frequency often
occurs.
These changes in the nasal-sinus environment lead to mucostasis
and bacterial colonization.
If the sinuses remain obstructed or the mucociliary. transport system
does not return to normal, a bacterial infection can ensue.
Scott-brown
5. Classification of infectious rhinosinusitis
Report of the Rhinosinusitis Task Force Committee Meeting. Otolaryngology and Head and Neck Surgery. 1997; 117:
51-68.
6. Conventional Criteria for Diagnosis of Sinusitis
Based on Presence of at Least 2 Major or 1 Major and 2 Minor Symptoms
IDSAGuideline for ABRS: CID.March 20, 2012
7. Acute rhinosinusitis-
◦ Acute onset of symptoms
◦ Duration of symptoms < 4
weeks
◦ Symptoms resolve
completely
◦ Streptococcus
pneumoniae (20%-45%)
and Haemophilus
influenzae (22%-35%) are
the predominant
organisms in adults,
whereas
◦ S. pneumoniae (30%-
43%), H. influenzae (20%-
28%), and Moraxella
catarrhalis (20%-28%) are
the predominant
organisms in children
8. Subacute rhinosinusitis
◦ Duration of symptoms >4 weeks to < 12 weeks
◦ Pathogens are same as ARS
Recurrent acute rhinosinusitis
◦ 4 or more episodes of acute rhinosinusitis per year, with each
lasting longer than 7 to 10 days,
◦ Complete recovery between attacks
◦ Symptom-free period of > 8 weeks between acute attacks in
absence of medical treatment
◦ Bacteriology and pathophysiology would be similar to those of
individual episodes of ABRS
9. Chronic rhinosinusitis
Duration of symptoms> 12 weeks
Persistent inflammatory changes on imaging > 4 weeks after
starting appropriate medical therapy
no intervening acute episodes
Unlike for ABRS, the role of bacteria in CRS is not well supported
CRS is an inflammatory disease, and it may or may not involve
pathogenic microbes.
Therefore, bacteria, fungi or viruses may be involved in some
cases
In those patients with CRS who do have potential pathogenic
bacteria, the most common organisms are Staphylococcus
species (55 percent) and Staphylococcus aureus (20 percent).
Some studies have shown a high prevalence of
Enterobacteriaceae organisms, anaerobes, Gram-negative
bacteria and fungi.
10. Acute exacerbations chronic rhinosinusitis
AECRS is a sudden worsening of the baseline CRS symptoms or
appearance of new symptoms
Complete resolution of acute (but not chronic) symptoms between episodes
There may be a change in the bacteriology of the disease
12. Acute rhinosinusitis in adults
Inflammation of nose and paranasal sinuses
≥ 2 symptoms, one of nasal
blockage/obstruction/congestion or nasal discharge
(ant/post nasal drip):
± facial pain/pressure
± reduction or loss of smell
EPOS March 2012
13. And either
endoscopic signs of:
◦ nasal polyps, and/or
◦ mucopurulent discharge from middle meatus and/or
◦ edema/mucosal obstruction in middle meatus
and/or
◦ CT changes:
◦ mucosal changes within ostiomeatal complex and/or
sinuses
For <12 weeks
4/26/12
14. Acute rhinosinusitis in children
Inflammation of nose and paranasal
sinuses
≥ 2 symptoms one of nasal
blockage/obstruction/congestion or
nasal discharge (ant/post nasal drip):
± facial pain/pressure
± cough
EPOS March 2012
15. Acute rhinosinusitis in children
And either
endoscopic signs of:
nasal polyps, and/or
mucopurulent discharge from middle meatus and/or
edema/mucosal obstruction in middle meatus
And/or
CT changes:
mucosal changes within the ostiomeatal complex and/or sinuses
For < 12 weeks
EPOS March 2012
16. Severity of disease in adult and children
Define disease severity:
Mild: VAS 0-3
Moderate: VAS 4-7
Severe: VAS 8-10
17. Acute rhinosinusitis can be divided into CommonCold
and post- viral rhinosinusitis. A small subgroup of post-viral
rhinosinusitis is caused by bacteria (ABRS).
EPOS March 2012
18. Classification of ARS in
adult/children
Common cold/ acute viral rhinosinusits :
◦ duration of symptoms for< 10 d
Acute post-viral rhinosinusitis:
◦ increase of symptoms after 5 d or persistent symptoms after 10 d with < 12 wk
duration.
ABS: ≥ 3 symptoms/signs
◦ Discoloured discharge (unilat predominance) and purulent secretion in nasi
◦ Severe local pain (unilat predominance)
◦ Fever (>38 °C)
◦ Elevated ESR/CRP
◦ ‘Double sickening’ (deterioration after initial milder of illness)
EPOS March 2012
19. Signs ofABS
At least 3 of:
-Discoloured d/c
-Severe local pain
-Fever
-Elevated ESR/CRP
-Double sickening
Postviral acute rhinosinusitis
Increase in symptoms after 5 d
Persistent symptom after 10 d
EPOS March 2012
20. Any of following clinical presentations are recommended for
identifying patients with acute bacterial vs viral rhinosinusitis
Onset with persistent S/S compatible with ARS ≥ 10 d without any
evidence of clinical improvement.
Onset with severe S/S of high fever ≥ 39 °C and purulent nasal
discharge or facial pain at least 3–4 consecutive d at beginning of
illness.
Onset with worsening S/S characterized by new onset of fever,
headache, increase in nasal discharge following typical viral URI
that lasted 5–6 d and were initially improving (‘‘doublesickening’’).
IDSAGuideline for ABRS: CID.March 20, 2012
21. Associated Factors
◦ Environmental Exposures( dampness in home ,air
pollution, irritants)
◦ Anatomical factors
septal deviation, paradoxical turbinate; nasal polyps, and choanal
obstruction by benign adenoid tissue, or odontogenic sources of
infection
◦ Allergy
individuals with allergies have a higher incidence of
developing both acute and chronic rhinosinusitis
EPOS March 2012
22. ◦ Ciliary impairment
Ciliary function diminished during viral and bacterial rhinosinusitis.
Exposure to cigarette smoke and allergic inflammation has been
shown to impair ciliary function.
Impaired mucociliary clearance in Allergic Rhinitis patients
predisposes patients to ARS
◦ Primary Ciliary Dyskinesia
◦ Smoking
◦ Laryngopharyngeal reflux
Pacheco-Galvan et al. 1997-2006 have shown significant associations between
GERD and sinusitis.
Recent systematic review, Flook and Kumar showed only poor association
between acid reflux, nasal symptoms, and ARS
EPOS March 2012
23. ◦ Anxiety and depression
Poor mental health, anxiety, or depression is associated with susceptibility
to ARS
Mechanisms are unclear.
◦ Drug resistance
◦ Concomitant Chronic Disease
Concomitant chronic disease (bronchitis, asthma, CVS disease, DM,) in
children has been associated with increased risk of developing ARS
secondary to influenza.
◦ Iatrogenic factors
Including surgery, medications, nasal packing or nasogastric tube
placement. EPOS March 2012
24. Pathophysiology
Acute rhinosinusitis develops in conjunction with an acute viral upper
respiratory tract infection.
Occur more commonly in predisposed individuals
The infection results in mucosal swelling with occlusion or
obstruction of the sinus ostia.
A reduction in oxygen tension occurs which can reduce mucociliary
transport and transudation of fluid into the sinuses.
The inflammation also results in changes in the mucous that
become more viscous and alterations in cilia beat frequency often
occurs.
These changes in the nasal-sinus environment lead to mucostasis
and bacterial colonization.
If the sinuses remain obstructed or the mucociliary. transport system
does not return to normal, a bacterial infection can ensue.
Scott-brown
26. Bacterial Culture
Microbiological investigations are not required for diagnosis of
ARS in routine practice. ( EPOS March 2012)
May be required in research settings, or in atypical or
recurrent disease
Maxillary sinus tap with culture is the gold standard for the
diagnosis of ABRS,
There is increasing interest in the role of endoscopic-guided
middle meatal cultures, but their reliability in children has not
been established
Nasopharyngeal cultures are unreliable and are not
recommended for microbiologic diagnosis of ABRS
Current accepted reference standard for culture is more than
10,000 colony forming units (CFU)/mL in sinus aspirate.
IDSA Guideline for ABRS: CID.March 20, 2012
27. Nasal endoscopy
Nasal endoscopy may be used to
visualize nasal and sinus anatomy
provide biopsy and microbiological samples.
confirm drainage
Evaluate treatment response
EPOS March 2012
28. C-Reactive Protein (CRP)
Raised in bacterial infection.
ARS: low or normal CRP may identify low
likelihood of positive bacterial infection
Limiting unnecessary antibiotic use.
CRP levels are significantly correlated with
changes in CT scans.
EPOS March 2012
29. ESR
ESR levels correlated with CT changes
in ARS
ESR >10 is predictive of sinus fluid levels
or sinus opacity on CT scan.
Raised ESR is predictive of positive
bacterial culture on sinus puncture or
lavage
EPOS March 2012
30. Procalcitonin
Indicates More severe bacterial
infection
There is no evidence of its
effectiveness as a biomarker in ARS.
EPOS March 2012
31. Nasal Nitric Oxide (NO)
Sensitive indicator of presence of
inflammation and ciliary dysfunction.
Very low levels: primary ciliary
dyskinesia, significant sinus obstruction.
Elevated levels: inflammation provided
ostiomeatal patency maintained
EPOS March 2012
32. Imaging
CT scan
◦ Modality of choice to confirm extent of pathology and
anatomy.
◦ Very severe disease, immuno-compromised pt, suspicion
of complications.
◦ Routine CT scan in ARS little useful information
Plain sinus X Rays
◦ Insensitive & limited usefulness
Ultrasound
◦ Insensitive & limited usefulness
EPOS March 2012
33. XVII. Which Imaging Is Most Useful for Severe
ABRS who suspected to have Suppurative
complication?
CT rather than MRI is recommended to
localize infection and to guide further
treatment.
IDSAGuideline for ABRS: CID.March 20, 2012
34. Algorithm for the management of acute bacterial rhinosinusitis
IDSAGuideline for ABRS: CID.March 20, 2012
35. Algorithm for the management of acute bacterial rhinosinusitis
IDSAGuideline for ABRS: CID.March 20, 2012
36. Algorithm for the management of acute bacterial rhinosinusitis
IDSAGuideline for ABRS: CID.March 20, 2012
40. Definition
Chronic Rhinosinusitis (with or without NP) in
adults
≥ 2 symptoms
one of which should be either nasal
blockage/obstruction/congestion or nasal
discharge(ant/post drip) or
± Facial pain/pressure
± reduction or loss of smell
for ≥12 weeks
EPOS 2012
41. CRSwNP: bilateral, endoscopically
visualised polyps in middle meatus.
CRSsNP: no visible polyps in middle
meatus
Definition
EPOS 2012
42. CRS in children
≥ 2 symptoms
◦ one of which should be either nasal
blockage/obstruction/congestion or nasal
discharge(ant/postnasal drip) or
◦ ± Facial pain/pressure
◦ ± Cough
for ≥12 weeks
EPOS 2012
43. Factor associated with CRS
Ciliary impairment
Allergy
Asthma
Aspirin sensitivity
Immunocompromised state
Genetic factor
Pregnancy and endocrine state
Local host factor
Biofilm
Environmental factor
Iatrogenic factor
H.pylori and laryngopharyngeal reflux
Osteitis
44. Pathophysiology
Scott-brown
The role of allergies has been strongly
suggested but not proven
Antigen-antibody reactions result in the
release of histamine and other mediators of
inflammation.
These mediators cause changes in vascular
permeability, destabilization of lysosomal
membranes and other reactions that produce
inflammation, mucosal swelling and ostia
obstruction
45. Pathophysiology
Scott-brown
Many cells and proteins that are involved with inflammatory
response have been implicated and are being investigated to
their roles in rhinosinusitis, particularly CRS.
These include, but are not limited to, eosinophils, neutrophils,
mast cells, T and B celis, immunoglobulins, interleukins,
tumour necrosis factor, major basic protein and a number of
other mediators of inflammation.
Other factors have also been identified that may play a role
in the development or perpetuation of CRS, including,
superantigens, biofilms and osteitis.
48. Biofilms
◦ Artificial or damaged biologic surface that formed
communicating organization of microorganisms surrounded
by a glycocalys
◦ Biofilms is relatively impervious to antibiotics and is never
eradicated
◦ Mechanical debridement- the only way to resolve biofilms
Osteitis
◦ Inflammatory bone changes were noted on
contralateral side in 52% of the animals (Khalid et al.
laryngoscope 2002)